Critical blood defense receptor CD163 mapped for first time
CD163 might not be the most exciting name in the world, but behind it lies one of the body's most important defense receptors ...
来自MSN5 个月
Study highlights potential for targeting macrophages to improve rheumatoid arthritis outcomes
Importantly, the identification of a dominant macrophage subtype (CD40-expressing CD206+CD163+) suggests targeting of CD40 signalling could represent a new strategy for patients who currently don ...